The global Vaccine for Influenza market size was valued at USD 8056.5 million in 2022 and is forecast to a readjusted size of USD 11570 million by 2029 with a CAGR of 5.3% during review period.
Report includes an overview of the development of the Vaccine for Influenza industry chain, the market status of 6 Months to 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), > 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analyzed the cutting-edge technology, patent, hot applications and market trends of Vaccine for Influenza.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
Regionally, the report analyzes the Vaccine for Influenza markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Vaccine for Influenza market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Vaccine for Influenza market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Vaccine for Influenza industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Units), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).
Industry Analysis: Report analyze the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Vaccine for Influenza market.
Regional Analysis: The report involves examining the Vaccine for Influenza market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behavior to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Vaccine for Influenza market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Vaccine for Influenza:
Company Analysis: Report covers individual Vaccine for Influenza manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behavior, preferences, and attitudes towards Vaccine for Influenza This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months to 3 Years, > 3 Years).
Technology Analysis: Report covers specific technologies relevant to Vaccine for Influenza. It assesses the current state, advancements, and potential future developments in Vaccine for Influenza areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Vaccine for Influenza market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
6 Months to 3 Years
> 3 Years
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Vaccine for Influenza product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccine for Influenza, with price, sales, revenue and global market share of Vaccine for Influenza from 2018 to 2023.
Chapter 3, the Vaccine for Influenza competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine for Influenza breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Vaccine for Influenza market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccine for Influenza.
Chapter 14 and 15, to describe Vaccine for Influenza sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Vaccine for Influenza
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Vaccine for Influenza Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Trivalent Influenza Vaccine
1.3.3 Quadrivalent Influenza Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Vaccine for Influenza Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 6 Months to 3 Years
1.4.3 > 3 Years
1.5 Global Vaccine for Influenza Market Size & Forecast
1.5.1 Global Vaccine for Influenza Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Vaccine for Influenza Sales Quantity (2018-2029)
1.5.3 Global Vaccine for Influenza Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Vaccine for Influenza Product and Services
2.1.4 Sanofi Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Vaccine for Influenza Product and Services
2.2.4 CSL Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Vaccine for Influenza Product and Services
2.3.4 GSK Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Viatris
2.4.1 Viatris Details
2.4.2 Viatris Major Business
2.4.3 Viatris Vaccine for Influenza Product and Services
2.4.4 Viatris Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Viatris Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Vaccine for Influenza Product and Services
2.5.4 AstraZeneca Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Hualan Bio
2.6.1 Hualan Bio Details
2.6.2 Hualan Bio Major Business
2.6.3 Hualan Bio Vaccine for Influenza Product and Services
2.6.4 Hualan Bio Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hualan Bio Recent Developments/Updates
2.7 Changchun Institute of Biological
2.7.1 Changchun Institute of Biological Details
2.7.2 Changchun Institute of Biological Major Business
2.7.3 Changchun Institute of Biological Vaccine for Influenza Product and Services
2.7.4 Changchun Institute of Biological Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Changchun Institute of Biological Recent Developments/Updates
2.8 Sinovac
2.8.1 Sinovac Details
2.8.2 Sinovac Major Business
2.8.3 Sinovac Vaccine for Influenza Product and Services
2.8.4 Sinovac Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sinovac Recent Developments/Updates
2.9 BCHT
2.9.1 BCHT Details
2.9.2 BCHT Major Business
2.9.3 BCHT Vaccine for Influenza Product and Services
2.9.4 BCHT Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BCHT Recent Developments/Updates
2.10 Jiangsu GDK
2.10.1 Jiangsu GDK Details
2.10.2 Jiangsu GDK Major Business
2.10.3 Jiangsu GDK Vaccine for Influenza Product and Services
2.10.4 Jiangsu GDK Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangsu GDK Recent Developments/Updates
2.11 KM Biologics
2.11.1 KM Biologics Details
2.11.2 KM Biologics Major Business
2.11.3 KM Biologics Vaccine for Influenza Product and Services
2.11.4 KM Biologics Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 KM Biologics Recent Developments/Updates
3 Competitive Environment: Vaccine for Influenza by Manufacturer
3.1 Global Vaccine for Influenza Sales Quantity by Manufacturer (2018-2023)
3.2 Global Vaccine for Influenza Revenue by Manufacturer (2018-2023)
3.3 Global Vaccine for Influenza Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Vaccine for Influenza by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Vaccine for Influenza Manufacturer Market Share in 2022
3.4.2 Top 6 Vaccine for Influenza Manufacturer Market Share in 2022
3.5 Vaccine for Influenza Market: Overall Company Footprint Analysis
3.5.1 Vaccine for Influenza Market: Region Footprint
3.5.2 Vaccine for Influenza Market: Company Product Type Footprint
3.5.3 Vaccine for Influenza Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Vaccine for Influenza Market Size by Region
4.1.1 Global Vaccine for Influenza Sales Quantity by Region (2018-2029)
4.1.2 Global Vaccine for Influenza Consumption Value by Region (2018-2029)
4.1.3 Global Vaccine for Influenza Average Price by Region (2018-2029)
4.2 North America Vaccine for Influenza Consumption Value (2018-2029)
4.3 Europe Vaccine for Influenza Consumption Value (2018-2029)
4.4 Asia-Pacific Vaccine for Influenza Consumption Value (2018-2029)
4.5 South America Vaccine for Influenza Consumption Value (2018-2029)
4.6 Middle East and Africa Vaccine for Influenza Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Vaccine for Influenza Sales Quantity by Type (2018-2029)
5.2 Global Vaccine for Influenza Consumption Value by Type (2018-2029)
5.3 Global Vaccine for Influenza Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Vaccine for Influenza Sales Quantity by Application (2018-2029)
6.2 Global Vaccine for Influenza Consumption Value by Application (2018-2029)
6.3 Global Vaccine for Influenza Average Price by Application (2018-2029)
7 North America
7.1 North America Vaccine for Influenza Sales Quantity by Type (2018-2029)
7.2 North America Vaccine for Influenza Sales Quantity by Application (2018-2029)
7.3 North America Vaccine for Influenza Market Size by Country
7.3.1 North America Vaccine for Influenza Sales Quantity by Country (2018-2029)
7.3.2 North America Vaccine for Influenza Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Vaccine for Influenza Sales Quantity by Type (2018-2029)
8.2 Europe Vaccine for Influenza Sales Quantity by Application (2018-2029)
8.3 Europe Vaccine for Influenza Market Size by Country
8.3.1 Europe Vaccine for Influenza Sales Quantity by Country (2018-2029)
8.3.2 Europe Vaccine for Influenza Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Vaccine for Influenza Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Vaccine for Influenza Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Vaccine for Influenza Market Size by Region
9.3.1 Asia-Pacific Vaccine for Influenza Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Vaccine for Influenza Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Vaccine for Influenza Sales Quantity by Type (2018-2029)
10.2 South America Vaccine for Influenza Sales Quantity by Application (2018-2029)
10.3 South America Vaccine for Influenza Market Size by Country
10.3.1 South America Vaccine for Influenza Sales Quantity by Country (2018-2029)
10.3.2 South America Vaccine for Influenza Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Vaccine for Influenza Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Vaccine for Influenza Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Vaccine for Influenza Market Size by Country
11.3.1 Middle East & Africa Vaccine for Influenza Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Vaccine for Influenza Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Vaccine for Influenza Market Drivers
12.2 Vaccine for Influenza Market Restraints
12.3 Vaccine for Influenza Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Vaccine for Influenza and Key Manufacturers
13.2 Manufacturing Costs Percentage of Vaccine for Influenza
13.3 Vaccine for Influenza Production Process
13.4 Vaccine for Influenza Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Vaccine for Influenza Typical Distributors
14.3 Vaccine for Influenza Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Vaccine for Influenza Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Vaccine for Influenza Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Vaccine for Influenza Product and Services
Table 6. Sanofi Vaccine for Influenza Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Vaccine for Influenza Product and Services
Table 11. CSL Vaccine for Influenza Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CSL Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Vaccine for Influenza Product and Services
Table 16. GSK Vaccine for Influenza Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Viatris Basic Information, Manufacturing Base and Competitors
Table 19. Viatris Major Business
Table 20. Viatris Vaccine for Influenza Product and Services
Table 21. Viatris Vaccine for Influenza Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Viatris Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Vaccine for Influenza Product and Services
Table 26. AstraZeneca Vaccine for Influenza Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 29. Hualan Bio Major Business
Table 30. Hualan Bio Vaccine for Influenza Product and Services
Table 31. Hualan Bio Vaccine for Influenza Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hualan Bio Recent Developments/Updates
Table 33. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 34. Changchun Institute of Biological Major Business
Table 35. Changchun Institute of Biological Vaccine for Influenza Product and Services
Table 36. Changchun Institute of Biological Vaccine for Influenza Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Changchun Institute of Biological Recent Developments/Updates
Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
Table 39. Sinovac Major Business
Table 40. Sinovac Vaccine for Influenza Product and Services
Table 41. Sinovac Vaccine for Influenza Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sinovac Recent Developments/Updates
Table 43. BCHT Basic Information, Manufacturing Base and Competitors
Table 44. BCHT Major Business
Table 45. BCHT Vaccine for Influenza Product and Services
Table 46. BCHT Vaccine for Influenza Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. BCHT Recent Developments/Updates
Table 48. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 49. Jiangsu GDK Major Business
Table 50. Jiangsu GDK Vaccine for Influenza Product and Services
Table 51. Jiangsu GDK Vaccine for Influenza Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jiangsu GDK Recent Developments/Updates
Table 53. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 54. KM Biologics Major Business
Table 55. KM Biologics Vaccine for Influenza Product and Services
Table 56. KM Biologics Vaccine for Influenza Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. KM Biologics Recent Developments/Updates
Table 58. Global Vaccine for Influenza Sales Quantity by Manufacturer (2018-2023) & (M Units)
Table 59. Global Vaccine for Influenza Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Vaccine for Influenza Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Vaccine for Influenza, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Vaccine for Influenza Production Site of Key Manufacturer
Table 63. Vaccine for Influenza Market: Company Product Type Footprint
Table 64. Vaccine for Influenza Market: Company Product Application Footprint
Table 65. Vaccine for Influenza New Market Entrants and Barriers to Market Entry
Table 66. Vaccine for Influenza Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Vaccine for Influenza Sales Quantity by Region (2018-2023) & (M Units)
Table 68. Global Vaccine for Influenza Sales Quantity by Region (2024-2029) & (M Units)
Table 69. Global Vaccine for Influenza Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Vaccine for Influenza Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Vaccine for Influenza Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Vaccine for Influenza Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Vaccine for Influenza Sales Quantity by Type (2018-2023) & (M Units)
Table 74. Global Vaccine for Influenza Sales Quantity by Type (2024-2029) & (M Units)
Table 75. Global Vaccine for Influenza Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Vaccine for Influenza Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Vaccine for Influenza Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Vaccine for Influenza Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Vaccine for Influenza Sales Quantity by Application (2018-2023) & (M Units)
Table 80. Global Vaccine for Influenza Sales Quantity by Application (2024-2029) & (M Units)
Table 81. Global Vaccine for Influenza Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Vaccine for Influenza Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Vaccine for Influenza Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Vaccine for Influenza Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Vaccine for Influenza Sales Quantity by Type (2018-2023) & (M Units)
Table 86. North America Vaccine for Influenza Sales Quantity by Type (2024-2029) & (M Units)
Table 87. North America Vaccine for Influenza Sales Quantity by Application (2018-2023) & (M Units)
Table 88. North America Vaccine for Influenza Sales Quantity by Application (2024-2029) & (M Units)
Table 89. North America Vaccine for Influenza Sales Quantity by Country (2018-2023) & (M Units)
Table 90. North America Vaccine for Influenza Sales Quantity by Country (2024-2029) & (M Units)
Table 91. North America Vaccine for Influenza Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Vaccine for Influenza Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Vaccine for Influenza Sales Quantity by Type (2018-2023) & (M Units)
Table 94. Europe Vaccine for Influenza Sales Quantity by Type (2024-2029) & (M Units)
Table 95. Europe Vaccine for Influenza Sales Quantity by Application (2018-2023) & (M Units)
Table 96. Europe Vaccine for Influenza Sales Quantity by Application (2024-2029) & (M Units)
Table 97. Europe Vaccine for Influenza Sales Quantity by Country (2018-2023) & (M Units)
Table 98. Europe Vaccine for Influenza Sales Quantity by Country (2024-2029) & (M Units)
Table 99. Europe Vaccine for Influenza Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Vaccine for Influenza Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Vaccine for Influenza Sales Quantity by Type (2018-2023) & (M Units)
Table 102. Asia-Pacific Vaccine for Influenza Sales Quantity by Type (2024-2029) & (M Units)
Table 103. Asia-Pacific Vaccine for Influenza Sales Quantity by Application (2018-2023) & (M Units)
Table 104. Asia-Pacific Vaccine for Influenza Sales Quantity by Application (2024-2029) & (M Units)
Table 105. Asia-Pacific Vaccine for Influenza Sales Quantity by Region (2018-2023) & (M Units)
Table 106. Asia-Pacific Vaccine for Influenza Sales Quantity by Region (2024-2029) & (M Units)
Table 107. Asia-Pacific Vaccine for Influenza Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Vaccine for Influenza Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Vaccine for Influenza Sales Quantity by Type (2018-2023) & (M Units)
Table 110. South America Vaccine for Influenza Sales Quantity by Type (2024-2029) & (M Units)
Table 111. South America Vaccine for Influenza Sales Quantity by Application (2018-2023) & (M Units)
Table 112. South America Vaccine for Influenza Sales Quantity by Application (2024-2029) & (M Units)
Table 113. South America Vaccine for Influenza Sales Quantity by Country (2018-2023) & (M Units)
Table 114. South America Vaccine for Influenza Sales Quantity by Country (2024-2029) & (M Units)
Table 115. South America Vaccine for Influenza Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Vaccine for Influenza Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Vaccine for Influenza Sales Quantity by Type (2018-2023) & (M Units)
Table 118. Middle East & Africa Vaccine for Influenza Sales Quantity by Type (2024-2029) & (M Units)
Table 119. Middle East & Africa Vaccine for Influenza Sales Quantity by Application (2018-2023) & (M Units)
Table 120. Middle East & Africa Vaccine for Influenza Sales Quantity by Application (2024-2029) & (M Units)
Table 121. Middle East & Africa Vaccine for Influenza Sales Quantity by Region (2018-2023) & (M Units)
Table 122. Middle East & Africa Vaccine for Influenza Sales Quantity by Region (2024-2029) & (M Units)
Table 123. Middle East & Africa Vaccine for Influenza Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Vaccine for Influenza Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Vaccine for Influenza Raw Material
Table 126. Key Manufacturers of Vaccine for Influenza Raw Materials
Table 127. Vaccine for Influenza Typical Distributors
Table 128. Vaccine for Influenza Typical Customers
List of Figures
Figure 1. Vaccine for Influenza Picture
Figure 2. Global Vaccine for Influenza Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Vaccine for Influenza Consumption Value Market Share by Type in 2022
Figure 4. Trivalent Influenza Vaccine Examples
Figure 5. Quadrivalent Influenza Vaccine Examples
Figure 6. Global Vaccine for Influenza Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Vaccine for Influenza Consumption Value Market Share by Application in 2022
Figure 8. 6 Months to 3 Years Examples
Figure 9. > 3 Years Examples
Figure 10. Global Vaccine for Influenza Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Vaccine for Influenza Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Vaccine for Influenza Sales Quantity (2018-2029) & (M Units)
Figure 13. Global Vaccine for Influenza Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Vaccine for Influenza Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Vaccine for Influenza Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Vaccine for Influenza by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Vaccine for Influenza Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Vaccine for Influenza Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Vaccine for Influenza Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Vaccine for Influenza Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Vaccine for Influenza Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Vaccine for Influenza Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Vaccine for Influenza Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Vaccine for Influenza Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Vaccine for Influenza Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Vaccine for Influenza Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Vaccine for Influenza Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Vaccine for Influenza Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Vaccine for Influenza Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Vaccine for Influenza Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Vaccine for Influenza Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Vaccine for Influenza Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Vaccine for Influenza Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Vaccine for Influenza Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Vaccine for Influenza Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Vaccine for Influenza Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Vaccine for Influenza Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Vaccine for Influenza Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Vaccine for Influenza Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Vaccine for Influenza Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Vaccine for Influenza Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Vaccine for Influenza Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Vaccine for Influenza Consumption Value Market Share by Region (2018-2029)
Figure 52. China Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Vaccine for Influenza Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Vaccine for Influenza Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Vaccine for Influenza Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Vaccine for Influenza Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Vaccine for Influenza Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Vaccine for Influenza Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Vaccine for Influenza Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Vaccine for Influenza Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Vaccine for Influenza Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Vaccine for Influenza Market Drivers
Figure 73. Vaccine for Influenza Market Restraints
Figure 74. Vaccine for Influenza Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Vaccine for Influenza in 2022
Figure 77. Manufacturing Process Analysis of Vaccine for Influenza
Figure 78. Vaccine for Influenza Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
